Fri, January 17, 2020

by: WOPRAI

Eric Sheridan Maintained (AMZN) at Strong Buy with Increased Target to $115 on, Jan 17th, 2020

by: WOPRAI

Susan Roth Katzke Maintained (C) at Buy with Increased Target to $90 on, Jan 17th, 2020

by: WOPRAI

Robert Moskow Maintained (BYND) at Hold with Increased Target to $125 on, Jan 17th, 2020

by: WOPRAI

John Glass Downgraded (CAKE) to Sell and Decreased Target to $38 on, Jan 17th, 2020

by: WOPRAI

Jamie Cook Maintained (CAT) at Buy with Increased Target to $173 on, Jan 17th, 2020

by: WOPRAI

Timothy Thein Maintained (CAT) at Strong Buy with Increased Target to $170 on, Jan 17th, 2020

by: WOPRAI

Brian Schwartz Downgraded (ADSK) to Hold on, Jan 17th, 2020

by: WOPRAI

Brian Schwartz Upgraded (ADBE) to Buy and Held Target at $410 on, Jan 17th, 2020

by: WOPRAI

Matthew Harrison Maintained (ARGX) at Buy with Increased Target to $180 on, Jan 17th, 2020

by: WOPRAI

Christopher Harris Maintained (ARES) at Buy with Increased Target to $50 on, Jan 17th, 2020

by: WOPRAI

Stuart Gordon Downgraded (ARMK) to Hold and Increased Target to $43 on, Jan 17th, 2020

by: WOPRAI

Christopher Harris Maintained (APO) at Buy with Increased Target to $61 on, Jan 17th, 2020

by: WOPRAI

Saul Martinez Maintained (USB) at Hold with Decreased Target to $57 on, Jan 17th, 2020

by: WOPRAI

Jeff Kvaal Maintained (AAPL) at Hold with Increased Target to $280 on, Jan 17th, 2020

by: WOPRAI

Jeff Kvaal Maintained (AAPL) at Hold with Increased Target to $70 on, Jan 17th, 2020

by: WOPRAI

Katy Huberty Maintained (AAPL) at Buy with Increased Target to $92 on, Jan 17th, 2020

by: WOPRAI

Richard Valera Maintained (ALTR) at Strong Buy with Increased Target to $44 on, Jan 17th, 2020

by: WOPRAI

A.J. Rice Initiated (AMED) at Buy and Held Target at $206 on, Jan 17th, 2020

by: WOPRAI

Matthew Harrison Maintained (AMGN) at Buy with Decreased Target to $277 on, Jan 17th, 2020

by: WOPRAI

Matthew Harrison Initiated (BGNE) at Buy and Held Target at $210 on, Jan 17th, 2020

by: WOPRAI

Matthew Harrison Maintained (BIIB) at Sell with Increased Target to $270 on, Jan 17th, 2020

by: WOPRAI

Chris Terry Upgraded (AA) to Strong Buy on, Jan 17th, 2020

by: WOPRAI

Kenneth Herbert Maintained (BA) at Hold with Decreased Target to $350 on, Jan 17th, 2020

by: WOPRAI

Richard Shane Maintained (AXP) at Hold with Increased Target to $134 on, Jan 17th, 2020

by: WOPRAI

Eric Sheridan Upgraded (SNAP) to Strong Buy and Increased Target to $24 on, Jan 17th, 2020

by: WOPRAI

Sophie Karp Upgraded (SO) to Buy and Held Target at $71 on, Jan 17th, 2020

by: WOPRAI

Patrick O"Shaughnessy Downgraded (SPGI) to Hold on, Jan 17th, 2020

by: WOPRAI

Jonathan Petersen Upgraded (VTR) to Strong Buy and Increased Target to $68 on, Jan 17th, 2020

by: WOPRAI

David Lebovitz Maintained (ASND) at Buy with Increased Target to $148 on, Jan 17th, 2020

by: WOPRAI

Sophie Karp Maintained (AVA) at Sell with Increased Target to $42 on, Jan 17th, 2020

by: WOPRAI

Jonathan Petersen Upgraded (AVB) to Strong Buy and Increased Target to $248 on, Jan 17th, 2020

by: WOPRAI

Matt Bryson Upgraded (WDC) to Buy and Increased Target to $83 on, Jan 17th, 2020

by: WOPRAI

Kyle White Initiated (WCN) at Strong Buy and Held Target at $106 on, Jan 17th, 2020

by: WOPRAI

Brian Schwartz Upgraded (BL) to Buy and Held Target at $75 on, Jan 17th, 2020

by: WOPRAI

Eric Sheridan Maintained (BKNG) at Hold on, Jan 17th, 2020

by: WOPRAI

Michael Carrier Reiterated (BK) at Hold with Decreased Target to $50 on, Jan 17th, 2020

by: WOPRAI

Betsy Graseck Maintained (BK) at Sell with Decreased Target to $51 on, Jan 17th, 2020

by: WOPRAI

David Nierengarten Downgraded (SYRS) to Hold and Held Target at $90 on, Jan 17th, 2020

by: WOPRAI

Bryan Bergin Initiated (TTEC) at Buy and Held Target at $50 on, Jan 17th, 2020

by: WOPRAI

Michael Weinstein Downgraded (CMS) to Hold on, Jan 17th, 2020

by: WOPRAI

Allison Landry Maintained (CSX) at Buy with Increased Target to $28 on, Jan 17th, 2020

by: WOPRAI

Walter Spracklin Maintained (CSX) at Hold with Increased Target to $25 on, Jan 17th, 2020

by: WOPRAI

Katy Huberty Downgraded (CDW) to Sell and Decreased Target to $124 on, Jan 17th, 2020

by: WOPRAI

Sophie Karp Maintained (XEL) at Buy with Decreased Target to $66 on, Jan 17th, 2020

by: WOPRAI

Anthony Pettinari Maintained (WY) at Strong Buy with Increased Target to $35 on, Jan 17th, 2020

by: WOPRAI

John Glass Upgraded (YUM) to Buy and Increased Target to $118 on, Jan 17th, 2020

by: WOPRAI

Kyle White Initiated (WM) at Hold and Held Target at $123 on, Jan 17th, 2020

by: WOPRAI

Andrew Strelzik Maintained (WING) at Buy with Decreased Target to $105 on, Jan 17th, 2020

David Lebovitz Maintained (ASND) at Buy with Increased Target to $148 on, Jan 17th, 2020

David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $140 to $148 on, Jan 17th, 2020.

David has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David

  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $186 on, Tuesday, October 22nd, 2019